[Retracted] Comparative Analysis of Efficacy and Prognosis of Hemodialysis and Peritoneal Dialysis for End-Stage Renal Disease: A Meta-analysis

Table 1

Basic characteristics of the included literature.

Study	Year	Sample time	Cases treat/con	Age (years)		Sex ratio (M/FM)		Study design	Treatment time (months)	NOS	Outcome measures
				Treat	Con	Treat	Con
Qiu jing	2015	2011.01~2013.02	50/50			26/24	28/22	RCT	3	6	③④⑤⑥
Qiu junfei	2019	2015.03~2017.03	30/30			18/12	17/13	RCT	6	7	③⑥
Cui dongfeng	2016	2013~2014	40/40			23/17	22/18	RCT	6	6	①②③⑤
Tian yuan	2019	2017.01~2018.12	48/48			29/19	29/19	RCT	3	7	②③④
Zhou pengyu	2021	2018.01~2020.01	40/40			22/18	24/16	RCT	6	7	②③④⑤⑥
Fu tianwen	2019	2013.04~2018.04	34/34			17/17	18/16	RCT	6	7	③④
Wang jie	2015	2013.06~2014.08	30/30	42~69	42~69	18/12	18/12	RCT	3	6	③④⑤⑥
Liu jia	2019	2017.01~2017.12	25/25			13/12	15/10	RCT	6	7	②③④⑤⑥
He laiming	2020	2015.01~2018.12	30/30			17/13	16/14	RCT	6	7	②③④⑥
Haijiao Jin	2016	2013.01~2014.12	98/82			56/40	44/38	RCT	3	8	①②④⑤⑥
Shen yan	2016	2010.01~2013.01	46/48			29/17	31/17	RCT	6	8	①②③④⑤⑥
Xing an	2014	2012.02~2013.06	52/88			27/25	51/37	RCT	12	6	②③④⑤⑥
Huang zanwei	2012	2011.05~2012.05	40/40	36~73	37~75	22/18	24/16	RCT	6	6	①③④⑥
Xiujuan Zang	2020	2005.01~2015.12	309/233			179/130	123/110	RCT	12	8	①②⑥

Note: Treat: Treatment group; Con: control group; M: male; FM: female; RCT: randomized controlled trial; ①: 1-year survival rate; ②: adverse effects rate; ③: serum creatinine; ④: blood urea nitrogen; ⑤: hemoglobin; ⑥: albumin.